Remember Joe is a salesman, tells you whatever you want to hear to keep you quiet. His two year record tells the story. Past 9 months Covid excitement unable to capitalize 5 cents in pps. His leadership, blurry vision and results could be a major problem for institutional support and future planning. I bought into his vision late 2018 and early 2019 but he had his chance. I'm still supporting Purcell and von Hofe !!! I'm concerned if NGIO ever goes public leadership/toxic support will dump GNBT shares and continue to drain shareholders value. Imo ego more important then shareholders interest. Cheerleading done for now , show some substantial progress .....Altucell, AE37, REVENUE, NASDAQ listing/ requirements for both companies, Analyst coverage, VALUATION, Patel progress, AZ status, funding in the bank, COVID testing results, Institutional support and stop the dilution.
Exciting times ahead!!
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links